{"version":"1.0","provider_name":"GRAIL","provider_url":"https:\/\/grail.com","author_name":"Meredith Hemler","author_url":"https:\/\/grail.com\/stories\/author\/mhemler\/","title":"GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting - GRAIL","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"L7lMv0Fytj\"><a href=\"https:\/\/grail.com\/press-releases\/grail-announces-promising-new-data-with-early-detection-blood-test-to-be-presented-at-2019-american-society-of-clinical-oncology-annual-meeting\/\">GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/grail.com\/press-releases\/grail-announces-promising-new-data-with-early-detection-blood-test-to-be-presented-at-2019-american-society-of-clinical-oncology-annual-meeting\/embed\/#?secret=L7lMv0Fytj\" width=\"600\" height=\"338\" title=\"&#8220;GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting&#8221; &#8212; GRAIL\" data-secret=\"L7lMv0Fytj\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26@2x-1.jpg","thumbnail_width":423,"thumbnail_height":172,"description":"\u2014 Methylation Technology Identifies Tumor Tissue of Origin of Multiple Cancer Types with High Accuracy \u2014 \u2014 Initial Survival Analysis of CCGA Participants Adds to Evidence Suggesting Technology Preferentially Detects More Aggressive Cancers \u2014 MENLO PARK, Calif., May 15, 2019\u2013GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced that new [&hellip;]"}